Archives for September 8, 2003

← 2003

Investing in paprika

Paprika, used as a food colourant and flavour enhancer throughout the world, has attracted the focus of regional economic initiatives, governments and agribusiness from South Africa to Zambia. In Zambia, family agribusiness Bimzi has organised 3000...

Health: the market for mutual funds

Mutual funds investing in health and biotechnology stocks have provided little shelter from the bear market this year. Managers of these funds say an aging population underpins demand for health care products and services and the long term outlook is...

EU food industry supports 'balanced framework'

On the eve of the 5th WTO Ministerial Conference in Cancún, the Confederation of the food and drink industries of the EU, the voice of the €600 billion European food and drink industry, urges WTO members to come to a balanced framework agreement on...

Time to take tea seriously?

Early results on a new topical cream containing compounds found in tea suggest that it could soon be used to help fight skin cancer, the most common type of cancer in the United States.

Natural sleep aid could worsen asthma symptoms

Taking supplements of melatonin, used to combat insomnia or jet lag, could pose health risks for people with asthma say researchers in the US. Higher levels of melatonin are associated with an overnight loss of lung function in asthma patients.

Cranberry treatment for stroke patients

Chemicals from cranberries could be used to help recovery from stroke, particularly in its earliest stages when the most severe damage occurs, said researchers at an American Chemical Society meeting yesterday.

Expo East: proof of mainstream swing?

Natural Products Expo East organisers say last weekend's show broke all previous attendance records, with an unprecedented diversity reflecting the changing demographics of natural product fans to include the mainstream consumer.

Roche to close US vitamin E facility

Roche Vitamins is to close its Nutley, New Jersey-based vitamin E production facility ahead of schedule, to ease pressure from current weak vitamin prices. Production of the vitamin will be moved to a new state-of-the-art facility to open in...

Forbes raises funding for pharma developments

Canadian biotech firm Forbes Medi-Tech announced today it has raised US$4.65 million by way of a private placement, providing the company with the necessary resources to 'expand its pharmaceutical pipeline and continue development of its...